Sunday, December 14, 2025 | 12:04 PM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch

AIIMS studying effects of HCQ on Covid-19 patients as deaths near 500 mark

About 480 patients wille be observed over 8 weeks; trial results of American drug Remdesivir also awaited

Hydroxychloroquine, coronavirus, covid-19, drug, drugs, pharma, pharmaceutical
premium

The total confirmed cases of Covid-19 in India reached 14,378 on Saturday, including 26 naval personnel serving at the Western Naval Command in Mumbai

Ruchika Chitravanshi New Delhi
The All India Institute of Medical Sciences (AIIMS) is conducting a study on Hydroxychloroquine (HCQ) as a therapeutic and prophylactic drug on Covid-19, the Indian Council of Medical Research (ICMR) has said, even as it awaits the trial results of the American drug Remdesivir on the pandemic. 

The total confirmed cases of Covid-19 in India reached 14,378  on Saturday, including 26 naval personnel serving at the Western Naval Command in Mumbai. Most of the cases are reported to be asymptomatic and have been traced to a single sailor who tested positive on April 7. 

Following this, the navy has started a contact